Y
Yasan Yeh
Researcher at University of California, San Diego
Publications - 8
Citations - 98
Yasan Yeh is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Nanoparticle & Dielectrophoresis. The author has an hindex of 4, co-authored 7 publications receiving 69 citations. Previous affiliations of Yasan Yeh include University of California.
Papers
More filters
Journal ArticleDOI
Recovery of Drug Delivery Nanoparticles from Human Plasma Using an Electrokinetic Platform Technology.
Stuart Ibsen,Avery Sonnenberg,Carolyn E. Schutt,Rajesh Mukthavaram,Yasan Yeh,Inanc Ortac,Sareh Manouchehri,Santosh Kesari,Sadik C. Esener,Michael J. Heller +9 more
TL;DR: The first demonstration of the recovery and analysis of drug delivery nanoparticles from undiluted human plasma samples through the use of a new electrokinetic platform technology is presented and can be broadly applied to the recovery of nanoparticle from high conductance fluids in a wide range of applications.
Journal ArticleDOI
A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model
Ebru Erdal,Murat Demirbilek,Yasan Yeh,Öznur Akbal,Laura E. Ruff,Damla Bozkurt,Ahmet Çabuk,Yasin Senel,Berrak Gumuskaya,Oktay Algin,Şeyda Çolak,Sadik C. Esener,Emir Baki Denkbaş +12 more
TL;DR: In vivo MR imaging in a mouse breast cancer model shows effective intratumoral distribution of both nanoparticles in the tumor tissue, but magnetosome demonstrated higher distribution than HSA-coated iron oxide nanoparticles according to fluorescence microscopy evaluation.
Journal ArticleDOI
Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles
Guankui Wang,Halli Benasutti,Jessica F. Jones,Guixin Shi,Michael Benchimol,Sandeep C. Pingle,Santosh Kesari,Yasan Yeh,Li-En Hsieh,Yu-Tsueng Liu,Anthony D. Elias,Dmitri Simberg +11 more
TL;DR: Blood-stable MBs targeted to several surface markers for isolation of breast tumor cells were developed and can promote research and clinical applications involving primary tumors and metastases and multitargeted anti-human EpCAM/EGFR MBs bound all cell lines with over 95% efficiency.
Journal ArticleDOI
Nanoparticle Encapsulated L-Asparaginase
TL;DR: A novel nanoparticle enzyme encapsulation technology that overcomes the limitation of immune responses to enzymes or PEG is developed, indicating that the SHELS effectively shield the enzyme from the antibodies.